**Core Concept**
Plasma cell dyscrasias are a group of disorders characterized by the proliferation of malignant plasma cells in the bone marrow. The presence of plasma cells in the bone marrow can be evaluated using various parameters, including the percentage of plasma cells, the presence of lytic lesions, and the detection of monoclonal proteins (M proteins) in the serum.

**Why the Correct Answer is Right**
The presence of >10% plasma cells in the bone marrow without lytic lesions and with M protein in the serum is characteristic of monoclonal gammopathy of undetermined significance (MGUS). In MGUS, the plasma cells are present in the bone marrow in numbers greater than 10%, but less than 60%, and there are no lytic lesions or end-organ damage. The presence of M protein in the serum is a hallmark of MGUS, indicating the production of a monoclonal immunoglobulin by the malignant plasma cells.

* The absence of lytic lesions rules out multiple myeloma, a plasma cell dyscrasia characterized by bone destruction and end-organ damage.
* The presence of >10% plasma cells is a key criterion for MGUS, differentiating it from normal plasma cell populations.
* M protein in the serum is a diagnostic feature of MGUS, indicating the presence of a monoclonal immunoglobulin.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the criteria for MGUS.
**Option B:** This option is incorrect because it is not a recognized plasma cell dyscrasia.
**Option C:** This option is incorrect because it is a feature of multiple myeloma, not MGUS.

**Clinical Pearl / High-Yield Fact**
MGUS is a premalignant condition that carries a risk of progression to multiple myeloma or other plasma cell dyscrasias. Patients with MGUS require regular monitoring with serum protein electrophoresis (SPEP) and bone marrow biopsies to detect any changes in their condition.

**Correct Answer: D. Monoclonal Gammopathy of Undetermined Significance (MGUS)**